Sort
53,477 grants matching “addiction”
Vaping Cessation among youth: Evaluating the feasibility and efficacy of a virtual in-person CBT and an app-based CBT4CBT
$1,003,164Suchitra Krishnan-Sarin · Yale University · R01 · FY2024 · CA
Novel fluorescent sensors for imaging neuromodulation
$1,002,861Yang Dan · University Of California Berkeley · U01 · FY2021 · NS
Novel Dopamine D3 Receptor Ligands
$1,002,774Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2013 · DA
Alliance to Disseminate Addiction Prevention and Treatment (ADAPT): A Statewide Learning Health System to Reduce Substance Use among Justice-Involved Youth in Rural Communities.
$1,002,621Matthew Aalsma · Indiana University Indianapolis · UG1 · FY2020 · DA
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model
$1,002,597Giordano De Guglielmo · University Of California, San Diego · U01 · FY2025 · DA
Metabolic basis of B cell lineage leukemia relapse
$1,002,111Markus Mãschen · Yale University · R35 · FY2021 · CA
STRESS AND PTSD MECHANISMS AS TARGETS FOR PHARMACOTHERAPY OF ALCOHOL ABUSE, ADDICTION AND RELAPSE
$1,002,099Seattle Institute For Biomedical And Clinical Research · · FY2013 · Department of Defense
A staged, comprehensive investigation for developing insular deep brain stimulation to treat refractory chronic pain
$1,002,003William Jeffrey Elias · University Of Virginia · UH3 · FY2023 · NS
Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction Treatment
$1,001,961Roger Brooks Bagwell · Actuated Medical, Inc. · R44 · FY2024 · AA
Development of KLS-13019 for Neuropathic Pain
$1,001,774Douglas Eric Brenneman · Kannalife Sciences, Inc. · R42 · FY2023 · NS
Center for the Development of Novel Medications for Cocaine Dependence
$1,001,222Kyle Matthew Kampman · University Of Pennsylvania · U54 · FY2017 · DA
17/24 Healthy Brain and Child Development National Consortium
$1,001,022Sylia Wilson · University Of Minnesota · U01 · FY2021 · DA
Administrative Core
$1,000,548Frederick Gerard Moeller · University Of Texas Hlth Sci Ctr Houston · P50 · FY2012 · DA
Hallucinogens and 5-HT Receptors: Mechanisms and Effects
$1,000,180Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2009 · DA
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets
$1,000,001Hongkang Zhang · Quiver Bioscience Inc. · R44 · FY2021 · CA
IGF::OT::IGF RELAPSE PREVENTION MOTION AND VOICE VIDEO GAME; POP: 9/2/2014-9/1/2016; N44DA-14-4419 SBIR Phase II (Topic 150) Modification to Remove IT Risk Assessment requirements.
$1,000,000Daniel Greenberg · Media Rez, Llc · N44 · FY2014 · DA
NIDA Clinical Trials Network: New York Node
$1,000,000John P Rotrosen · New York University School Of Medicine · UG1 · FY2021 · DA
Early Stage Development of a Selective Kappa Opioid Receptor (KOR) Antagonist to Treat Alcohol Use Disorder
$1,000,000Ronald N Marcus · Cerecor. Inc. · U44 · FY2016 · AA
NIDA CENTGER FOR GENETIC STUDIES
$1,000,000Rutgers The St Univ Of Nj New Brunswick · N01 · FY2000 · DA
SCC-CIVIC-FA Track B: Participatory Action Research to Enhance Equity and Prevent Moral Injury in Community Paramedicine
$1,000,000Miranda Worthen · San Jose State University Foundation · · FY2023 · CSE
Mid Southern Primary Care Networks Node
$999,998Li-Tzy T Wu · Duke University · UG1 · FY2019 · DA
BETTER TOGETHER: INTEGRATING MOUD IN AFRICAN AMERICAN COMMUNITY SETTINGS. SEPTEMBER 15, 2023 TO JANUARY 31, 2026. N01DA-22-2253. TASK ORDER 75N95023F00004 (TO8).
$999,995Jennifer McCormack · The Emmes Company, Llc · N01 · FY2023 · DA
Micronized salsalate in a parenteral formulation is a safe and effective analgesic for acute postoperative pain management
$999,994Joel Steven Ross · Rh Nanopharmacueticals L.L.C. · R44 · FY2021 · NS
Development of Nociceptin Receptor Agonists for Alcohol Use Disorders, Period of Performance 09/15/15 - 09/14/17; CPFF
$999,993Nurulain Zaveri · Astraea Therapeutics, Llc · N44 · FY2015 · HD
Novel biologic to treat chemotherapy-induced neuropathic pain
$999,967Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2022 · CA